ABCA6 and neoplasm: Accordingly, tumor-related death occurred in 30.4% (7 out of 23) of patients with high expression of ABCA6, but in 69.6% (16 out of 23) of patients with low expression of the transporter (p = 0.046, Fisher’s exact test).